Nimotop is the brand name for the medication nimodipine. It belongs to the class of calcium-channel blockers that act on vascular smooth muscle. Nimotop is prescribed to prevent delayed cerebral ischemia that can occur following a subarachnoid hemorrhage. The drug works by inhibiting the entry of calcium ions into smooth muscle cells of cerebral blood vessels. Calcium influx is essential for the contraction of these vessels, so blocking it leads to vasodilation. Vasodilation improves blood flow in the brain and decreases the likelihood of vessel narrowing. By improving cerebral circulation, Nimotop helps protect neuronal tissue from ischemic damage. The overall therapeutic effect is a reduction in the incidence of poor outcomes related to cerebral vasospasm.

Nimotop is a calcium channel blocker used to prevent cerebral vasospasm after subarachnoid hemorrhage. It works by blocking l-type voltage-gated calcium channels in arterial smooth muscle. This blockade reduces calcium influx, leading to relaxation of cerebral blood vessels. By improving blood flow to the brain, the drug helps protect neurons from ischemic injury. The medication is absorbed rapidly when given orally, reaching therapeutic levels throughout the body. Clinical studies have shown that Nimotop lowers the incidence of delayed neurological deficits associated with vasospasm.

Nimotop may cause dizziness, headache, nausea, and vomiting in some patients. It can also lead to low blood pressure, especially when standing up quickly. Some individuals experience swelling of the ankles or feet. Elevated liver enzymes have been reported in rare cases. Less commonly, patients may notice constipation or dry mouth. These effects are generally mild and usually resolve on their own. Long-term use is not associated with major complications in the majority of cases.

Some patients taking Nimotop may experience headache. Dizziness and lightheadedness are also reported. Nausea and abdominal discomfort can occur. Flushing, characterized by facial redness, may be observed. Fatigue and weakness are common complaints. Low blood pressure leading to faintness may develop. Swelling of the ankles or feet has been noted in some cases.